# Assessment of the Usefulness of Hemopatch in Coronary Artery Bypass Graft Surgery

Study · id `cardio:ct-nct03340090` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03340090](<https://clinicaltrials.gov/study/NCT03340090>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03340090

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT03340090. Randomized; no masking; primary purpose treatment. Start 2018-03-20 (actual); primary completion 2019-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT03340090, source copy `cardio:ctgov-nct03340090-2019-08-09`, retrieved 2026-10-26)
- Started: 2018-03-20 (actual) (ClinicalTrials.gov record NCT03340090, source copy `cardio:ctgov-nct03340090-2019-08-09`, retrieved 2026-10-26)
- Primary completion: 2019-12-31 (anticipated) (ClinicalTrials.gov record NCT03340090, source copy `cardio:ctgov-nct03340090-2019-08-09`, retrieved 2026-10-26)
- Completion: 2019-12-31 (anticipated) (ClinicalTrials.gov record NCT03340090, source copy `cardio:ctgov-nct03340090-2019-08-09`, retrieved 2026-10-26)
- Countries: Poland (ClinicalTrials.gov record NCT03340090, source copy `cardio:ctgov-nct03340090-2019-08-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03340090-2019-08-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Assessment of the Usefulness of Hemopatch in Coronary Artery Bypass Graft Surgery
- Acronym: Hemopatch
- Condition: CHD - Coronary Heart Disease
- Intervention (Device): Medical Device Hemopatch-PEG-coated collagen patch
- Lead sponsor: Medical University of Lodz
- Lead sponsor class: OTHER
- Collaborator: Baxter Healthcare Corporation
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as a collaborator: Baxter Healthcare Corporation (`cardio:org-baxter-healthcare-corporation`)

## Provenance

Content hash: c27270a0e298b28e5034e589a354e0f7ec876ca4f6bebd55edb7f99e1d920a48
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
